President's Note

July 2014

Dear Colleagues

As you are well aware, EAACI is dedicated to raising awareness of the damage allergic disease causes millions of people. Over the past few months we have made great strides in reaching out to the European Parliament through a number of different methods, including the Written Declaration campaign as well as welcoming some of Europe’s key decision makers to the EAACI Congress 2014 in Copenhagen.

This month we took another step closer to help push this issue to the top of the agenda by attending a special event at the European Parliament in Strasbourg. It gave us the opportunity to discuss what could be done to promote the cause of allergies in the new European Parliament, bringing together many stakeholders concerning the specialty.

We were welcomed by Finnish MEP Sirpa Pietikäinen, one of the main driving forces behind our Written Declaration campaign, along with several MEPs and representatives. Additionally colleagues from the European Federation of Allergy and Airways Diseases Patients Associations (EFA) and the European Biopharmaceutrical Enterprises were on hand to offer their expertise into how we can progress over the coming years.

Being able to discuss the many factors and hurdles each separate entity faces proved incredibly valuable in establishing an effective roadmap to increase the visibility of allergy sufferers. It is promising that we have come so far in such a short space of time, but it was clear that there is still a long way to go before we can truly congratulate ourselves.

I have no doubt that we will reach our target of strengthening the specialty significantly over the next few years. The support of EAACI’s members and affiliates is crucial in doing this and I thank you for your efforts so far.

I am sure that together we can considerably reduce the suffering of those with allergies and successfully turn around this public health problem of pandemic proportions.

Nikos Papadopolous
EAACI President

Last updated 31 October 2014